Herpes zoster and post-herpetic neuralgia--a clinical trial of aspirin in chloroform for anodyne

J Assoc Physicians India. 1998 Apr;46(4):337-40.

Abstract

Pain associated with Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) has been a challenging task to manage with ease. Topical aspirin dissolved in chloroform is an effective means of reducing pain due to HZ and PHN in most patients. The locus of pain origin and analgesia induced by topical aspirin is supposed to be at cutaneous free nerve ending pain receptors. The present study was conduced in fifty two patients of HZ and PHN. Pain intensity before and after the application of drug was measured with help of Sort Form McGill Pain Questionnaire (SE-MPQ). Most of the patients experienced relief of pain within 1-5 minutes after the aspirin-chloroform application. Maximum relief was achieved in about 30-40 minutes and persisted for 5-6 hrs. In the beginning 3-4 applications were required but frequency decreased gradually as the pain abated.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Aspirin / administration & dosage*
  • Chloroform / administration & dosage*
  • Drug Combinations
  • Female
  • Herpes Zoster / complications*
  • Herpes Zoster / diagnosis
  • Herpes Zoster / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Neuralgia / drug therapy*
  • Neuralgia / etiology*
  • Pain Measurement
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Drug Combinations
  • Chloroform
  • Aspirin